Moreover, by specifically causing ADRM1 to lose its function, the agent RA190 blocks the nuclear translocation of NF-κB and the consequent activation of the NF-κB signalling pathway in HCC cells [36]. Here, NFKB1 is linked to hepatocellular carcinoma.